Nancy Rollins1, Timothy Booth2, Michael C Morriss2, Pablo Sanchez3, Roy Heyne4, Lina Chalak4. 1. Department of Radiology, Children's Medical Center and the University of Texas Southwestern Medical Center, Dallas, Texas; Department of Pediatrics, Children's Medical Center and the University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: nancy.rollins@childrens.com. 2. Department of Radiology, Children's Medical Center and the University of Texas Southwestern Medical Center, Dallas, Texas. 3. Department of Pediatrics, Nationwide Children's Hospital, Columbus, Ohio. 4. Department of Pediatrics, Children's Medical Center and the University of Texas Southwestern Medical Center, Dallas, Texas.
Abstract
BACKGROUND: Magnetic resonance imaging is a surrogate biomarker for major neurodevelopmental disabilities in survivors of perinatal hypoxic-ischemic encephalopathy because injury to the basal ganglia/thalami is highly predictive of major neuromotor and cognitive problems. Major disabilities and the appearance of neonatal magnetic resonance imaging are improved with therapeutic hypothermia. We evaluated neurodevelopmental outcomes when conventional magnetic resonance imaging showed minimal or no brain injury. METHODS: Institutional review board-approved series of 62 infants (≥36 weeks; ≥1800 g; 34 boys/28 girls) cooled for hypoxic-ischemic encephalopathy between 2005 and 2011 who underwent neonatal magnetic resonance imaging and Bayley Scales of Infant and Toddler Development-III at 22 ± 7 months of age. Magnetic resonance imaging at 5-14 (mean 8) days was scored as normal (score = 0), showing focal gray or white matter injury only (score = 1), or basal ganglia/thalamic and/or watershed lesions with or without more extensive hemispheric injury (score = 2). Sensitivity, specificity, and positive and negative predictive values for magnetic resonance scores 0 and 1 and statistical interaction between magnetic resonance imaging score and age at magnetic resonance imaging were determined. RESULTS: Magnetic resonance score = 0 was seen in 35/62 patients; 26/35 (74%) were typically developing, seven (20%) had moderate and two (6%) had severe delay. Magnetic resonance score = 1 was seen in 17/62 (27%) patients; 5/17 (29%) were normal, 11/17 (65%) had moderate delay, and 1/17 (6%) had severe neurodevelopmental delay. Of the 52 patients with magnetic resonance scores of 0 and 1, 40% were abnormal. The negative predictive value of a normal magnetic resonance imaging was 74%. For score 1, sensitivity was 95% (confidence interval 63%-83%), specificity 84% (confidence interval 70%-90%), positive predictive value 84% (confidence interval 71%-93%), and negative predictive value 74% (confidence interval 62%-82%). CONCLUSIONS: Caution is warranted when prognosticating about neurodevelopmental status in early childhood after hypoxic ischemic encephalopathy with cooling, and longer follow-up studies are needed to determine the prognostic significance of a neonatal magnetic resonance imaging showing no or minor degrees of brain injury.
BACKGROUND: Magnetic resonance imaging is a surrogate biomarker for major neurodevelopmental disabilities in survivors of perinatal hypoxic-ischemicencephalopathy because injury to the basal ganglia/thalami is highly predictive of major neuromotor and cognitive problems. Major disabilities and the appearance of neonatal magnetic resonance imaging are improved with therapeutic hypothermia. We evaluated neurodevelopmental outcomes when conventional magnetic resonance imaging showed minimal or no brain injury. METHODS: Institutional review board-approved series of 62 infants (≥36 weeks; ≥1800 g; 34 boys/28 girls) cooled for hypoxic-ischemicencephalopathy between 2005 and 2011 who underwent neonatal magnetic resonance imaging and Bayley Scales of Infant and Toddler Development-III at 22 ± 7 months of age. Magnetic resonance imaging at 5-14 (mean 8) days was scored as normal (score = 0), showing focal gray or white matter injury only (score = 1), or basal ganglia/thalamic and/or watershed lesions with or without more extensive hemispheric injury (score = 2). Sensitivity, specificity, and positive and negative predictive values for magnetic resonance scores 0 and 1 and statistical interaction between magnetic resonance imaging score and age at magnetic resonance imaging were determined. RESULTS: Magnetic resonance score = 0 was seen in 35/62 patients; 26/35 (74%) were typically developing, seven (20%) had moderate and two (6%) had severe delay. Magnetic resonance score = 1 was seen in 17/62 (27%) patients; 5/17 (29%) were normal, 11/17 (65%) had moderate delay, and 1/17 (6%) had severe neurodevelopmental delay. Of the 52 patients with magnetic resonance scores of 0 and 1, 40% were abnormal. The negative predictive value of a normal magnetic resonance imaging was 74%. For score 1, sensitivity was 95% (confidence interval 63%-83%), specificity 84% (confidence interval 70%-90%), positive predictive value 84% (confidence interval 71%-93%), and negative predictive value 74% (confidence interval 62%-82%). CONCLUSIONS: Caution is warranted when prognosticating about neurodevelopmental status in early childhood after hypoxic ischemicencephalopathy with cooling, and longer follow-up studies are needed to determine the prognostic significance of a neonatal magnetic resonance imaging showing no or minor degrees of brain injury.
Authors: Mary Rutherford; Serena Counsell; Joanna Allsop; James Boardman; Olga Kapellou; David Larkman; Jo Hajnal; David Edwards; Frances Cowan Journal: Pediatrics Date: 2004-10 Impact factor: 7.124
Authors: Steven P Miller; Vijay Ramaswamy; David Michelson; A James Barkovich; Barbara Holshouser; Nathaniel Wycliffe; David V Glidden; Douglas Deming; J Colin Partridge; Yvonne W Wu; Stephen Ashwal; Donna M Ferriero Journal: J Pediatr Date: 2005-04 Impact factor: 4.406
Authors: Mary A Rutherford; Denis Azzopardi; Andrew Whitelaw; Frances Cowan; S Renowden; A David Edwards; Marianne Thoresen Journal: Pediatrics Date: 2005-10 Impact factor: 7.124
Authors: E Mercuri; D Ricci; F M Cowan; D Lessing; M F Frisone; L Haataja; S J Counsell; L M Dubowitz; M A Rutherford Journal: Pediatrics Date: 2000-08 Impact factor: 7.124
Authors: A J Barkovich; B L Hajnal; D Vigneron; A Sola; J C Partridge; F Allen; D M Ferriero Journal: AJNR Am J Neuroradiol Date: 1998-01 Impact factor: 3.825
Authors: Terrie E Inder; Rod W Hunt; Colin J Morley; Lee Coleman; Michael Stewart; Lex W Doyle; Susan E Jacobs Journal: J Pediatr Date: 2004-12 Impact factor: 4.406
Authors: A Barnett; E Mercuri; M Rutherford; L Haataja; M F Frisone; S Henderson; F Cowan; L Dubowitz Journal: Neuropediatrics Date: 2002-10 Impact factor: 1.947
Authors: Peter D Gluckman; John S Wyatt; Denis Azzopardi; Roberta Ballard; A David Edwards; Donna M Ferriero; Richard A Polin; Charlene M Robertson; Marianne Thoresen; Andrew Whitelaw; Alistair J Gunn Journal: Lancet Date: 2005 Feb 19-25 Impact factor: 79.321
Authors: Alison G Cahill; Amit M Mathur; Christopher D Smyser; Robert C Mckinstry; Kimberly A Roehl; Julia D López; Terrie E Inder; George A Macones Journal: Am J Perinatol Date: 2016-12-07 Impact factor: 1.862
Authors: Monica E Lemmon; Matthias W Wagner; Thangamadhan Bosemani; Kathryn A Carson; Frances J Northington; Thierry A G M Huisman; Andrea Poretti Journal: Dev Neurosci Date: 2017-01-18 Impact factor: 2.984
Authors: C Prempunpong; L F Chalak; J Garfinkle; B Shah; V Kalra; N Rollins; R Boyle; K-A Nguyen; I Mir; A Pappas; P Montaldo; S Thayyil; P J Sánchez; S Shankaran; A R Laptook; G Sant'Anna Journal: J Perinatol Date: 2017-11-02 Impact factor: 2.521
Authors: Jacqueline Salas; Nihaal Reddy; Emanuele Orru; Kathryn A Carson; Raul Chavez-Valdez; Vera Joanna Burton; Carl E Stafstrom; Frances J Northington; Thierry A G M Huisman Journal: J Neuroimaging Date: 2018-10-16 Impact factor: 2.486